GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹3,328 Cr | ₹1,609 Cr | ₹3,877 Cr | ₹3,593 Cr | ₹3,159 Cr |
What is the latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹3,328 Cr |
Mar2024 | ₹1,609 Cr |
Mar2023 | ₹3,877 Cr |
Mar2022 | ₹3,593 Cr |
Mar2021 | ₹3,159 Cr |
How is Net Current Assets of GLENMARK PHARMACEUTICALS Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹3,328 Cr | 106.80 | |
Mar2024 | ₹1,609 Cr | -58.49 | |
Mar2023 | ₹3,877 Cr | 7.92 | |
Mar2022 | ₹3,593 Cr | 13.75 | |
Mar2021 | ₹3,159 Cr | - |
Compare Net Current Assets of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹56,845.0 Cr | -3% | 3.8% | 26.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,451.0 Cr | 2.1% | 0.3% | -9.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,727.0 Cr | -0% | 1.1% | 13.4% | Stock Analytics | |
CIPLA | ₹124,533.0 Cr | -1.1% | -3.2% | -4.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,673.0 Cr | 3.4% | 0.2% | 8.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,629.0 Cr | -0.7% | 2% | 0.7% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -3% |
3.8% |
26.7% |
SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses